HDL Small measures the count of small, nascent HDL particles that are just beginning their maturation cycle. These particles are less effective at reverse cholesterol transport than their larger, more mature counterparts.
Elevated small HDL with low large HDL can indicate impaired HDL maturation. The particles are being produced but not maturing into fully functional cardioprotective forms. This pattern is more informative than HDL-C alone in some contexts, but remains a supporting marker.
Optimal HDL Small (ION): 3000-8000 nmol/L.
Typically re-tested every 12 weeks.
Small HDL particles are not damaged versions of large ones. They are the youngest, most protein-dense form HDL takes, and they are counted separately from the single HDL cholesterol value on a standard lipid panel. A result outside the typical range is a reason to look wider with a clinician, not an answer by itself.
HDL Small (ION) is the measured concentration of the smallest high-density lipoprotein particles in a blood sample, reported as a particle count in nmol/L rather than as the amount of cholesterol those particles carry.
The ION part refers to ion mobility analysis, a laboratory method that separates lipoprotein particles by physical size and counts each size band directly. The output is a distribution rather than one figure, so small, medium and large HDL each receive their own number.
HDL is a family of particles, not a single molecule. Particles differ in diameter, in density, and in the proteins and lipids they carry, and those differences are what define the recognised HDL subclasses 1. Small HDL sits at the dense, protein-rich end of that spectrum, carrying proportionally more protein and less cholesterol than the large, buoyant particles at the other end.
The size bands also trace a lifecycle. Newly formed HDL starts out small and disc-shaped, built around apolipoprotein A-I with relatively little lipid on board. As the particle takes up free cholesterol from cells and converts it to cholesteryl ester, it fills out, becomes spherical and moves up the size scale, which is why HDL heterogeneity is tied to the steps of reverse cholesterol transport 3. Enzymes and transfer proteins then remodel particles in both directions, so the mix circulating at any moment reflects how quickly that cycle is turning rather than a fixed trait.
Because the subpopulations differ in composition, they also differ in what they do, and research describes distinct biological functions across HDL particle subpopulations rather than one uniform HDL activity 2. That is the whole premise of measuring size bands separately.
It matters because a standard HDL cholesterol value measures cargo rather than carriers, and research suggests that size-defined HDL subpopulations play distinct roles in cardiovascular disease 4.
Two people can share an identical HDL cholesterol result while carrying very different numbers and sizes of particles. One may carry many small particles, another a smaller number of large ones. Splitting HDL by size is an attempt to make that difference visible.
Several strands of work sit behind the interest in the small band specifically.
The practical value of all this is directional, not decisive. A subclass profile adds texture to a lipid panel and can prompt a closer look at inflammation, insulin handling and the rest of your lipids. It does not establish a diagnosis, and no single size band is read in isolation.
Most laboratories report HDL Small (ION) against a typical reference range of roughly 1000 to 15000 nmol/L, while FitScript's optimal range is narrower, at 3000 to 8000 nmol/L.
| Range type | HDL Small (ION) |
|---|---|
| Typical lab reference range | 1000 to 15000 nmol/L |
| FitScript optimal range | 3000 to 8000 nmol/L |
Reference ranges vary by laboratory, by age and sex, and by the method used to separate the particles, so read your result against the range printed on your own report before comparing it to anything else. FitScript's optimal range is an optimization target, not a diagnostic cut-off, and sitting outside it does not mean something is wrong.
Notice how wide the standard range is. That width reflects genuine biological spread across healthy people, which is part of why a single value carries less information than a trend measured the same way, at the same laboratory, under the same conditions.
A high HDL Small (ION) result means your blood contains more small HDL particles than the typical reference range, which describes your particle distribution and does not name a condition.
Particle subclass counts produce no symptoms. Nobody feels a high small HDL count, and these results are usually found because advanced lipid testing was ordered for another reason. Whatever symptoms are present at the time belong to something else, not to the number.
As for causes, a high small particle count can reflect a high total HDL particle number, or a shift in the distribution towards the small end because particles are not maturing into larger ones at the usual rate. Composition is also sensitive to the state you are in when blood is drawn, and research indicates that a range of clinical and laboratory parameters affect HDL particle composition 11. Remodelling by the enzymes and transfer proteins that move cholesteryl ester between particles sits behind much of that variability 3.
Over the long run, a high small count is interpreted next to the medium and large bands rather than alone, because the subpopulations defined by size appear to play different roles 4. That is the honest position. A raised value is worth discussing with a clinician alongside your full lipid panel, your inflammatory markers and your metabolic picture, rather than being read as good news or bad news on its own.
A low HDL Small (ION) result means fewer small HDL particles are circulating than the typical reference range, which again is an observation about distribution rather than a diagnosis.
Like a high result, a low one causes no symptoms you could notice. It is found on paper, not in how you feel.
Timing matters here, because a sample drawn during an acute illness may not represent your usual state.
The outcome signals attached to low small HDL are the reason this band gets attention. Low levels of small HDL particles have been reported to predict, though not to influence, the risk of sepsis 9, and research suggests HDL particle populations relate more broadly to the risk of infection 8. In people with chronic kidney disease, low concentrations of the medium-sized band were associated with incident cardiovascular disease 10, a reminder that the clinical context around the number shapes how it is read.
A low value that is well outside the range printed on your report is worth discussing with a clinician promptly, particularly if it was drawn during an illness or alongside other suboptimal lipid or inflammatory markers. It is not a result to ignore, and it is not a result to panic over.
Several things move this number that have nothing to do with your long-term health, which is why the conditions around the blood draw matter as much as the figure itself.
If a prescription therapy enters the conversation about your lipids, a licensed provider evaluates whether it is appropriate after reviewing you. No article can make that call, and dosing and administration decisions belong with that provider.
FitScript does not currently test HDL Small (ION) in a panel, so if you want this number it will come from advanced lipid testing ordered elsewhere.
If you already have a result, you can upload your labs and Atlas, FitScript's AI health advisor, will read it alongside the rest of your markers. Membership covers 150+ biomarkers tested per year, including the standard lipid markers that give a small particle count its context, and Atlas writes your FitScript from your own biology, turning each observation into what is worth watching and what is worth raising with your clinician.
For tracking, consistency beats frequency. Retest under the same fasting state, at a similar time of day, through the same laboratory and method, and read the direction of travel across the small, medium and large bands together rather than chasing a single figure. Where a prescription option is considered, a licensed provider reviews you and decides whether it is appropriate.
A small particle count makes sense only next to the rest of the lipid picture, so these are the markers usually read with it.
HDL Small (ION) counts the smallest HDL particles rather than measuring the cholesterol inside them, which is information a standard lipid panel cannot give you. Typical laboratory ranges are wide, FitScript's optimal range is narrower, and neither a high nor a low value names a condition by itself. The useful move is to read it beside your other lipid markers and your clinical context, then repeat the test under matched conditions. This article is educational and is not medical advice. Discuss your results and any treatment options with a clinician or licensed provider who can review your full history.
It measures how many of the smallest high-density lipoprotein particles are circulating in your blood, reported as a particle count in nmol/L. It counts carriers rather than measuring the cholesterol inside them, which is why it reports a different kind of information from a standard HDL cholesterol value.
No. HDL cholesterol tells you how much cholesterol all your HDL particles carry in total, while the size-split counts tell you how that cholesterol is distributed across small, medium and large particles. The two are read together, not one instead of the other.
A typical laboratory reference range runs from about 1000 to 15000 nmol/L. FitScript's optimal range is narrower, 3000 to 8000 nmol/L, and that narrower band is an optimization target rather than a diagnostic cut-off. Always check the range printed on your own report, since ranges vary by lab, method, age and sex.
Neither on its own. A high count describes your particle distribution and does not name a condition. It is interpreted next to the medium and large bands, your other lipid markers and your clinical history, which is a conversation to have with a clinician.
Follow the instructions given by the laboratory or the clinician ordering the test. Fasting state can shift HDL particle size distribution, so the more important point is consistency. Use the same fasting state each time so that a change in the number reflects a change in you.
Lipoprotein particle counts do not produce symptoms at any level. These results are found through testing, not through how you feel, which is exactly why they are measured rather than guessed at.
Not currently in a panel. If you already have a result from advanced lipid testing done elsewhere, you can upload your labs and Atlas, FitScript's AI health advisor, will read it alongside your other markers.
Bring the full report to a clinician rather than acting on one line of it, and mention anything unusual around the draw, such as a recent illness or a change in your eating pattern. Do not start or stop any medicine on your own. A licensed provider decides whether any treatment is appropriate after reviewing you.